| Mrs Julie M Schneider, LPC | |
|
3398 E Maria Dr, Stevens Point, WI 54481-1362 | |
| (715) 341-7441 | |
| (715) 341-9178 |
| Full Name | Mrs Julie M Schneider |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 3398 E Maria Dr, Stevens Point, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336453570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 3781-125 (Wisconsin) | Primary |
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Illumina, Inc. today announced it will collaborate with the University of Oxford to sequence the whole genomes of 500 individuals afflicted with a range of life-threatening diseases that pose major challenges in diagnosis, treatment, and care. Illumina HiSeq™ 2000 systems will be used to generate sequence data for the 500 genomes.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
The Barth Syndrome Foundation recently announced awardees from its 2017 grant cycle. Miriam Greenberg, Ph.D., professor of biological sciences in the College of Liberal Arts and Sciences at Wayne State University and a resident of Ann Arbor, Michigan, received a one-year, $50,000 grant for the project, "Cardiolipin activates pyruvate dehydrogenase (PDH) - a potential new target for treatment of Barth syndrome."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Julie M Schneider, LPC 3398 E Maria Dr, Stevens Point, WI 54481-1362 Ph: (715) 341-7441 | Mrs Julie M Schneider, LPC 3398 E Maria Dr, Stevens Point, WI 54481-1362 Ph: (715) 341-7441 |
News Archive
Illumina, Inc. today announced it will collaborate with the University of Oxford to sequence the whole genomes of 500 individuals afflicted with a range of life-threatening diseases that pose major challenges in diagnosis, treatment, and care. Illumina HiSeq™ 2000 systems will be used to generate sequence data for the 500 genomes.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
The Barth Syndrome Foundation recently announced awardees from its 2017 grant cycle. Miriam Greenberg, Ph.D., professor of biological sciences in the College of Liberal Arts and Sciences at Wayne State University and a resident of Ann Arbor, Michigan, received a one-year, $50,000 grant for the project, "Cardiolipin activates pyruvate dehydrogenase (PDH) - a potential new target for treatment of Barth syndrome."
› Verified 3 days ago
Mrs. Katie Rose Tryba, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5541 Us Highway 10 E Ste 10, Stevens Point, WI 54482 Phone: 920-733-2065 | |
Todd Harold Kuhn, LPC, MS, CADC III Counselor Medicare: Medicare Enrolled Practice Location: 209 Prentice St N, Stevens Point, WI 54481 Phone: 715-344-4611 Fax: 715-344-8127 | |
Ms. Karolee A. Krause, NCC, SAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 817 Whiting Ave, Stevens Point, WI 54481 Phone: 715-345-5897 | |
Kathy Berg, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2900 Hoover Rd, Suite B, Stevens Point, WI 54481 Phone: 715-544-4435 Fax: 715-952-4995 | |
Vicky Kolasinski, MSE, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5541 Hwy 10 East, Suite B, Stevens Point, WI 54481 Phone: 715-345-9690 Fax: 715-345-2938 | |
Jessica Wilharms, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3233a Business Park Dr Ste 304, Stevens Point, WI 54482 Phone: 715-544-4435 | |
Monica Kroeplin, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1466 Water St Ste 2, Stevens Point, WI 54481 Phone: 715-341-6672 Fax: 715-341-8004 |